Henry Schein, Inc. (NASDAQ:HSIC) to Post Q4 2017 Earnings of $1.99 Per Share, Barrington Research Forecasts
Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Barrington Research lowered their Q4 2017 earnings estimates for shares of Henry Schein in a research note issued on Wednesday. Barrington Research analyst M. Petusky now anticipates that the company will earn $1.99 per share for the quarter, down from their prior forecast of $2.03. Barrington Research has a “Outperform” rating and a $198.00 price objective on the stock. Barrington Research also issued estimates for Henry Schein’s Q3 2018 earnings at $1.98 EPS.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the Zacks’ consensus estimate of $1.73 by $0.02. The company had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. Henry Schein’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.64 earnings per share.
Other equities research analysts also recently issued research reports about the company. Jefferies Group LLC restated a “hold” rating and set a $177.00 target price on shares of Henry Schein in a research report on Friday, July 21st. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday. Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Finally, Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective on the stock in a research report on Monday. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $185.56.
Henry Schein (NASDAQ HSIC) traded down 1.80% during midday trading on Thursday, hitting $166.60. The stock had a trading volume of 133,573 shares. The stock has a market capitalization of $13.19 billion, a price-to-earnings ratio of 24.35 and a beta of 1.09. The company’s 50 day moving average price is $182.39 and its 200-day moving average price is $175.07. Henry Schein has a 52 week low of $146.23 and a 52 week high of $186.99.
Large investors have recently added to or reduced their stakes in the stock. SpiderRock Advisors LLC purchased a new stake in Henry Schein during the first quarter worth $102,000. Lee Financial Co purchased a new stake in Henry Schein during the second quarter worth $161,000. Westside Investment Management Inc. purchased a new stake in Henry Schein during the first quarter worth $168,000. JNBA Financial Advisors purchased a new stake in Henry Schein during the first quarter worth $170,000. Finally, Peddock Capital Advisors LLC increased its stake in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the last quarter. Institutional investors and hedge funds own 90.87% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.